Comment on

• Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides: a cost-benefit analysis.

  Destache CJ, Meyer SK, Bittner MJ, Hermann KG. Destache CJ, et al. Ther Drug Monit. 1990 Sep;12(5):419-26. doi: 10.1097/00007691-199009000-00003. Ther Drug Monit. 1990. PMID: 2127324 Clinical Trial.
• Does accepting pharmacokinetic recommendations impact hospitalization? A cost-benefit analysis.

  Destache CJ, Meyer SK, Rowley KM. Destache CJ, et al. Ther Drug Monit. 1990 Sep;12(5):427-33. doi: 10.1097/00007691-199009000-00004. Ther Drug Monit. 1990. PMID: 2127325 Clinical Trial.
• The impact of near-patient testing on the organisation and costs of an anticonvulsant clinic.

  Elliot K, Watson ID, Tsintis P, Gray J, Stewart MJ, Kadr H, Lawson DH. Elliot K, et al. Ther Drug Monit. 1990 Sep;12(5):434-7. doi: 10.1097/00007691-199009000-00005. Ther Drug Monit. 1990. PMID: 2293404